Aduhelm
Medicare Limits Coverage of Aduhelm to Patients in Clinical Trials
2022-04-07 22:17:02
by
Dan McCue
WASHINGTON — Despite pressure to go another way, Medicare on Thursday evening announced it will only cover the new Alzheimer’s disease drug Aduhelm for people participating in a clinical trial. The decision came as something of a surprise as Medicare... Read More
FDA Changes Prescribing Instructions for Controversial Alzheimer’s Drug
2021-07-08 17:38:20
by
Dan McCue
U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug. The announcement came through Biogen Inc., the maker of Aduhelm, which stated the update is intended to “clarify” the... Read More
Straight From The Well